Karpus Investment Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-103,623	Closed	-$10.4M	–	379
2021 Q3	$10.4M	Hold	103,623	–	–	0.31%	76
2021 Q2	$10.3M	Buy	103,623 +44,134	+74%	+$4.4M	0.31%	77
2021 Q1	$5.84M	Buy	+59,489	New	+$5.84M	0.18%	120